MC38 cells are immunogenic and exhibit high expression of the co-stimulatory molecules CD40 and CD86 on the surface of dendritic cells compared with CT26 colon cancer cells [79]; thus, PDT is more effective against MC38 tumor-bearing models compared with CT26 [80] or LLC [81] tumor-bearing models. The gene discussed is CD86; the disease is colonic neoplasm.